Dark

Check out our API

XTLB
XTL Biopharmaceuticals Ltd.
stock NASDAQ ADR

At Close

Feb 5, 2026 11:05:36 AM EST

1.10USD+2.804%(+0.03)64,920

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 5, 2026 9:12:30 AM EST

1.02USD-4.673%(-0.05)355

After-hours

Feb 5, 2026 4:43:30 PM EST

1.05USD-4.518%(-0.05)439

OverviewHistoricalExchangesShortsNews

Mar 5, 2021

10:10AM EST Mid-Morning Market Update: Markets Mixed; Big Lots Earnings Top Views Benzinga

09:56AM EST Shares of XTL Biopharmaceuticals Ltd. (XTLB) reached a 52-week high of $6.11 Friday morning, and are currently trading at $5.32, up $2.43 or 84.26%, with trading volume soaring over 6.16 million versus an average volume of 29K shares. RTTNews

05:24AM EST XTL Biopharmaceuticals Shares Trading Up 215% Premarket; Not Seeing Any News to Account for the Move Benzinga

Jan 14, 2021

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

Jan 13, 2021

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

Dec 30, 2020

08:16AM EST The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data Benzinga

Dec 29, 2020

08:09AM EST The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga

Dec 18, 2020

07:48AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data Benzinga

07:45AM EST The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data Benzinga

Dec 17, 2020

08:10AM EST The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga

Dec 15, 2020

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

Oct 30, 2020

08:09AM EDT The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts Benzinga

Oct 21, 2020

08:04AM EDT The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings Benzinga

Share